기업 프로필 · Healthcare

West Pharmaceutical Services Inc

WST · 미국
산업
Packaging
거래소
미국
국가 / 지역
USA
상장일
1978년 1월 13일
직원 수
10,800
웹사이트
www.westpharma.com
현재가
$327.95
실시간 · 2026년 6월 18일
적정 매수가
≤ $240
안전마진 진입가
베일리 성장 점수
44/100
다소 약함
내재가치 · 3단계 구간 현재가 $327.95 실시간 · 낙관적 내재가치 구간 내 · 상당한 기대가 선반영

종합 밸류에이션 구간 · 보수적 $135–$165 / 적정 $190–$240 / 낙관적 $280–$330. $327.95 기준, 낙관적 내재가치 구간 내 · 상당한 기대가 선반영.

보고서 발행 시 $321.8(2026년 5월 29일)

이 종목에 대한 리포트가 아직 해당 언어로 없습니다.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

시가총액US$228.61억
매출 (TTM)US$32.21억
EBITDAUS$8.7억
순이익률16.85%
ROE19.13%
PER (TTM)43.26
선행 PER38.31
PEG3.17
EPSUS$7.48
배당수익률0.26%
52주 범위US$206.12 – US$336.82
애널리스트 목표주가US$358.79
애널리스트 평가4.7 / 5

데이터 제공: EODHD, 보고 통화 기준 표시. 참고용일 뿐 투자 자문이 아닙니다.

연혁

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.

업계 내 위치

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.